Drug Shortage Report for TARO-LANSOPRAZOLE
Report ID | 215033 |
Drug Identification Number | 02402610 |
Brand name | TARO-LANSOPRAZOLE |
Common or Proper name | LANSOPRAZOLE |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | LANSOPRAZOLE |
Strength(s) | 15MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-12-01 |
Estimated end date | 2024-01-12 |
Actual end date | 2024-01-16 |
Shortage status | Resolved |
Updated date | 2024-02-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-02-08 | French | Compare |
v3 | 2024-02-08 | English | Compare |
v2 | 2024-01-05 | French | Compare |
v1 | 2024-01-05 | English | Compare |
Showing 1 to 4 of 4